JP2022525238A5 - - Google Patents
Info
- Publication number
- JP2022525238A5 JP2022525238A5 JP2021560506A JP2021560506A JP2022525238A5 JP 2022525238 A5 JP2022525238 A5 JP 2022525238A5 JP 2021560506 A JP2021560506 A JP 2021560506A JP 2021560506 A JP2021560506 A JP 2021560506A JP 2022525238 A5 JP2022525238 A5 JP 2022525238A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962827381P | 2019-04-01 | 2019-04-01 | |
| US62/827,381 | 2019-04-01 | ||
| PCT/US2020/025979 WO2020205875A1 (en) | 2019-04-01 | 2020-03-31 | Bispecific binding molecules that target the tumor microenvironment and an immune checkpoint protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525238A JP2022525238A (ja) | 2022-05-11 |
| JP2022525238A5 true JP2022525238A5 (https=) | 2024-02-28 |
Family
ID=72607367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560506A Pending JP2022525238A (ja) | 2019-04-01 | 2020-03-31 | 腫瘍微小環境および免疫チェックポイントタンパク質を標的とする二重特異性結合分子 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11718673B2 (https=) |
| EP (1) | EP3947449A4 (https=) |
| JP (1) | JP2022525238A (https=) |
| KR (1) | KR20220004067A (https=) |
| CN (1) | CN114127107B (https=) |
| AU (1) | AU2020252191A1 (https=) |
| CA (1) | CA3135838A1 (https=) |
| TW (1) | TW202102539A (https=) |
| WO (1) | WO2020205875A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298136A (en) | 2020-05-13 | 2023-01-01 | Bonum Therapeutics Inc | Preparations of protein complexes and methods of using them |
| WO2022105817A1 (en) * | 2020-11-18 | 2022-05-27 | Suzhou Transcenta Therapeutics Co., Ltd. | Bi-functional molecules |
| CN121511262A (zh) * | 2023-06-28 | 2026-02-10 | 北京哲源科技有限责任公司 | 靶向pd-l1和il-1的双特异性抗体及其用途 |
| WO2025119346A1 (en) * | 2023-12-07 | 2025-06-12 | LaNova Medicines Limited | Anp-dependent antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2714738B1 (en) * | 2011-05-24 | 2018-10-10 | Zyngenia, Inc. | Multivalent and monovalent multispecific complexes and their uses |
| JP2016514676A (ja) | 2013-03-15 | 2016-05-23 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 四価二重特異性抗体 |
| WO2015035365A1 (en) * | 2013-09-09 | 2015-03-12 | The Nohns Hopkins University | Targeting the m2-tumor associated macrophage for cancer therapy |
| US10227411B2 (en) * | 2015-03-05 | 2019-03-12 | Xencor, Inc. | Modulation of T cells with bispecific antibodies and FC fusions |
| BR112018006237A2 (pt) * | 2015-09-29 | 2018-10-09 | Celgene Corp | proteínas de ligação a pd-1 e métodos de uso das mesmas |
| AR108377A1 (es) | 2016-05-06 | 2018-08-15 | Medimmune Llc | Proteínas de unión biespecíficas y sus usos |
| WO2018049248A1 (en) * | 2016-09-09 | 2018-03-15 | Icellhealth Consulting Llc | Oncolytic virus equipped with bispecific engager molecules |
| US20200188528A1 (en) | 2016-12-19 | 2020-06-18 | Fred Hutchinson Cancer Research Center | Peptide-antibody compositions and methods of use thereof |
| CA3061874A1 (en) * | 2017-06-22 | 2018-12-27 | Novartis Ag | Il-1beta binding antibodies for use in treating cancer |
-
2020
- 2020-03-31 US US16/836,197 patent/US11718673B2/en active Active
- 2020-03-31 WO PCT/US2020/025979 patent/WO2020205875A1/en not_active Ceased
- 2020-03-31 CA CA3135838A patent/CA3135838A1/en active Pending
- 2020-03-31 CN CN202080034654.XA patent/CN114127107B/zh active Active
- 2020-03-31 JP JP2021560506A patent/JP2022525238A/ja active Pending
- 2020-03-31 TW TW109110936A patent/TW202102539A/zh unknown
- 2020-03-31 EP EP20784051.3A patent/EP3947449A4/en not_active Withdrawn
- 2020-03-31 KR KR1020217035631A patent/KR20220004067A/ko not_active Ceased
- 2020-03-31 AU AU2020252191A patent/AU2020252191A1/en not_active Abandoned